Sensible use of antisense: how to use oligonucleotides as research tools.
In the past decade, there has been a vast increase in the amount of gene sequence information that has the potential to revolutionize the way diseases are both categorized and treated. Old diagnoses, largely anatomical or descriptive in nature, are likely to be superceded by the molecular characterization of the disease. The recognition that certain genes drive key disease processes will also enable the rational design of gene-specific therapeutics. Antisense oligonucleotides represent a technology that should play multiple roles in this process.
Myers
K J
KJ
Department of Pharmacology, ISIS Pharmaceuticals, 2292 Faraday Ave, Carlsbad, CA 92008, USA. kmyers@isisph.com
Dean
N M
NM
D000818:Animals; D006801:Humans; D016376:Oligonucleotides, Antisense / Q000138:chemical synthesis; D012333:RNA, Messenger / Q000096:biosynthesis / Q000235:genetics
D016376:Oligonucleotides, Antisense; D012333:RNA, Messenger